Evidence map›Paper›PMID 35348303›Full record

ArticleACR open rheumatology2022

Coffee Consumption Reduces Gout Risk Independently of Serum Uric Acid Levels: Mendelian Randomization Analyses Across Ancestry Populations.

Yuya Shirai, Akiyoshi Nakayama, Yusuke Kawamura, Yu Toyoda, Masahiro Nakatochi, Seiko Shimizu, Nariyoshi Shinomiya, Yukinori Okada, Hirotaka Matsuo, Japan Gout Genomics Consortium (Japan Gout)

Abstract read
In one paragraph

Article in ACR open rheumatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuya ShiraiOsaka University Graduate School of Medicine, Suita, Japan.
Akiyoshi NakayamaNational Defense Medical College, Tokorozawa, Japan.ORCID https://orcid.org/0000-0002-6654-0726
Yusuke KawamuraNational Defense Medical College, Tokorozawa, Japan.
Yu ToyodaNational Defense Medical College, Tokorozawa, Japan.ORCID https://orcid.org/0000-0002-7411-0531
Masahiro NakatochiNagoya University Graduate School of Medicine, Nagoya, Japan.
Seiko ShimizuNational Defense Medical College, Tokorozawa, Japan.
Nariyoshi ShinomiyaNational Defense Medical College, Tokorozawa, Japan.
Yukinori OkadaOsaka University Graduate School of Medicine and Osaka University, Suita, Japan, and RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.ORCID https://orcid.org/0000-0002-0311-8472
Hirotaka MatsuoNational Defense Medical College, Tokorozawa, Japan.ORCID https://orcid.org/0000-0003-4302-8719
Japan Gout Genomics Consortium (Japan Gout)

Funding

Bioinformatics Initiative of Osaka University Graduate School of Medicine, Osaka UniversityGout and Uric Acid Foundation of JapanJapan Agency for Medical Research and Development JP20ek0109413Japan Agency for Medical Research and Development JP20ek0410075Japan Agency for Medical Research and Development JP20gm4010006Japan Agency for Medical Research and Development JP20km0405211Japan Agency for Medical Research and Development JP20km0405217Japan Society for the Promotion of Science 16H06277 [CoBiA]Japan Society for the Promotion of Science 16H06279 [PAGS]Japan Society for the Promotion of Science 17H04128Japan Society for the Promotion of Science 19H01021Japan Society for the Promotion of Science 19K19434Japan Society for the Promotion of Science 19K22786Japan Society for the Promotion of Science 20H00566Japan Society for the Promotion of Science 20K21834Japan Society for the Promotion of Science 20K23152Japan Society for the Promotion of Science 21KK0173Japan Society for the Promotion of Science 221S0001Japan Society for the Promotion of Science 221S0002Takeda Science Foundationthe Ministry of Defense
6 · The paper itself

Abstract

objectiveThe effects of coffee consumption on serum uric acid (SUA) levels and gout risk are controversial. There have hitherto been no reports based on Mendelian randomization (MR) analysis of its effects that consider pleiotropy. Here, we evaluated the effects of coffee consumption across ancestry populations, taking pleiotropy into account.

methodsWe performed the first MR analyses for coffee consumption on SUA levels and gout, considering pleiotropy. We used the following summary statistics of genome-wide association studies from a Japanese population: habitual coffee consumption (152,634 subjects), gout (3053 cases and 4554 controls), and SUA levels (121,745 subjects). In addition to fixed-effect inverse variance weighted (IVW) meta-analysis, we performed a robust evaluation of heterogeneity and removed several instruments for reasons of possible pleiotropy. Previous European datasets were also reevaluated while heterogeneity was considered.

resultsHabitual coffee consumption was significantly and inversely associated with gout (odds ratio [OR] = 0.29, 95% confidence interval [95% CI]: 0.16-0.51, P = 1.9 × 10

conclusionWith pleiotropy taken into account, our MR analyses revealed that coffee consumption can causally reduce gout risk, and that it may reduce gout risk independently of SUA levels.

Identifiers

PMID35348303
PMCPMC9190218

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.